Incomplete Immunity

By combining experimental data with computer models, researchers were able to predict a pathogen’s evolution toward more virulence.

Written byJim Daley
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

BYE BYE BIRDIE: A study suggests a weak immune response could drive pathogens toward greater virulence. MARIE READ

The paper
A.E. Fleming-Davies et al., “Incomplete host immunity favors the evolution of virulence in an emergent pathogen,” Science, 359:1030-33, 2018.

FINCH KILLER
Since 1994, an epidemic of conjunctivitis caused by the bacterium Mycoplasma gallisepticum has ravaged house finch (Haemorhous mexicanus) populations across North America. Arietta Fleming-Davies and Dana Hawley, disease ecologists at the University of San Diego and Virginia Tech, respectively, noted that many birds that had been infected remained susceptible to later infection. The phenomenon reminded Fleming-Davies of findings by other researchers that when a vaccine partially protects a host, it can drive a pathogen to evolve more virulence. (See “Do Pathogens Gain Virulence as Hosts Become More Resistant?The Scientist, October 2017.)

BIRD IN A CAGETo find out whether something similar was happening in finches, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

June 2018

Microbial Treasure

Newly discovered archaea reveal bizarre biology

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies